Financial Summary (Consolidated) for the Fiscal Year Ending March 2026 [Japanese Standards]

Overview of Business Performance

For the fiscal year ending March 2026, consolidated net sales were 718.16 billion yen (up 5.9% YoY), operating income was 24.48 billion yen (down 1.2% YoY), ordinary income was 26.33 billion yen (up 1.2% YoY), and net income attributable to owners of the parent was 13.39 billion yen (down 11.5% YoY). Although sales increased, operating income and net profit declined, mainly due to a decrease in senior-oriented condominium construction projects, soaring component prices, and one-time costs related to M&A activities.

Segment Performance

The Total Pack Produce business recorded net sales of 136.60 billion yen (up 2.6% YoY) and operating income of 10.81 billion yen (down 10.0% YoY). The Medical Supplies business posted net sales of 509.56 billion yen (up 7.3% YoY) and operating income of 7.48 billion yen (up 7.4% YoY). The Life Care business achieved net sales of 37.32 billion yen (up 1.8% YoY) and operating income of 2.22 billion yen (up 1.2% YoY). The Dispensing Pharmacy business reported net sales of 34.67 billion yen (up 3.6% YoY) and operating income of 4.00 billion yen (up 16.9% YoY).

Financial Position and Cash Flows

Total assets increased to 385.11 billion yen, net assets grew to 152.43 billion yen, and the equity ratio was 39.2%. Cash flows from operating activities resulted in an inflow of 22.08 billion yen, investing activities saw an outflow of 2.07 billion yen, and financial activities resulted in an outflow of 16.33 billion yen. The ending cash and cash equivalents balance was 78.60 billion yen.

Future Outlook

For the fiscal year ending March 2027, consolidated earnings are forecasted to be net sales of 740.00 billion yen (up 3.0% YoY), operating income of 26.00 billion yen (up 6.2% YoY), ordinary income of 26.50 billion yen (up 0.6% YoY), and net income attributable to owners of the parent of 16.00 billion yen (up 19.5% YoY). The planned dividend per share at year-end is 65 yen. Based on the 'SHIP VISION 2030' medium-term management plan, the company aims for an average annual sales growth rate of 5%, an operating profit margin of 4%, and ROE of 12%.